Sentences with phrase «in its share price over»

A surge in its share price over the past year has pushed its value over $ 30 billion.

A surge in its share price over the past year has pushed its value over $ 30 billion.MARK RALSTON AFP / Getty Images

After all, assuming a constant price - to - earnings multiple, a doubling in the share price over a five - year period only requires earnings - per - share to double, which translates to an annualized growth rate of 14.9 %.

In particular, valuations for many of the electric utilities appear to leave room for little upside in their share prices over the next 3 to 5 years.

As I mentioned at the top of this post, the KMI dividend yield has reached 6 % recently due to the dramatic drop in share price over the last few months and some recent dividend increases.

Shareholders have also seen no progress in the share price over the last two & a half years, which continues to fall well short of most reasonable estimates of underlying intrinsic value per share.

You are not taxed on the increase in the value of your investment caused by an increase in the share price over the year nor do you get deduct the «loss» if the share price declined over the year.

I also have a position in MFC Industrial, a company with exposure to metals and oil and gas (which, however, I will be selling shortly), a video game developer that is a net / net (Gravity Ltd.), a small position in RadioShack (made even smaller by the decline in share price over the past 2 years), and finally a short - term spinoff trade (Oil States International).

Smaller high - growth companies tend to outperform their larger peers over the long - term and hugely successful ones are referred to as the five or ten — baggers which is the term used to describe stocks which have increased five to ten times in share price over a length of time, usually three, five or ten years.

Not exact matches

One of the outcomes of the much ballyhooed housing summit earlier this week between Sousa, his federal counterpart Bill Morneau and Toronto mayor John Tory was a commitment to «sharing relevant data more regularly between governments to enhance understanding,» a move that seems comically late after prices in the region have surged double - digits over the past few months.

The share prices of big entertainment companies have been extremely volatile over the past year as investors try to assess the winners and losers in the changing video ecosystem.

In 2013, for example, Magnetar and several other hedge funds sued over the acquisition by 3M (mmm) of biometrics company Cogent, seeking about 55 % more money for their shares in the target, which they claimed were priced too loIn 2013, for example, Magnetar and several other hedge funds sued over the acquisition by 3M (mmm) of biometrics company Cogent, seeking about 55 % more money for their shares in the target, which they claimed were priced too loin the target, which they claimed were priced too low.

The company said in February that it planned to buy back up to $ 5 billion of stock over 2018 - 2020 to share the benefits of higher oil prices with investors.

Apple's stock dipped at the start of 2016 due to concerns over a slowdown in iPhone sales, though share prices have since rebounded into positive territory for the year amid investor optimism for the company's new line of products.

Over the past two years, Groupon's stock price has gone from $ 26 a share on its first day of trading in November 2011 to less than $ 3 a share a year later.

Sanofi said on Monday it would pay 45 euros per share in cash for Ablynx, a premium of 21.2 percent over its closing price on Friday - and more than double the price before Novo went public with its initial offer.

NEW YORK, April 13 - Oil prices extended recent gains and a gauge of global stocks eased on Friday as concern over a broader conflict in Syria left investors nervous, while U.S. bank shares led Wall Street lower.

However analysts point to a bounce in Teva's shares over the past four months and a slowing in the rate of decline of U.S. generic drug prices as bright spots.

Shareholders approved the sale, which paid them $ 13.65 in cash for each share of common stock, a 37 % premium over the recent average closing price.

Exploration firm Red River Resources has seen its share price jump by over 80 per cent after it entered into a $ 6.5 million agreement with the administrators of collapsed explorer Kagara, for the sale of its projects in northern Queensland.

When you purchase a broad swath of equities, say an S&P 500 index fund, the returns you can expect over the next decade or so comprise four building blocks: the starting dividend yield, projected growth in real earnings per share, expected inflation, and the expected change in «valuation» — that is, the expansion or contraction in the price / earnings (P / E) multiple.

He said Blue Apron is «turning the corner on well - publicized operational issues» that dragged its share price from $ 10 in June to a little over $ 3 in current trading.

The Chinese group is offering S$ 3.38 in cash per share, representing 81 percent premium over its 12 - month volume weighted average price and a 25 percent premium over its last full trading day before the announcement.

Sanofi said on Monday it would pay 45 euros per share in cash for Ablynx, a premium of 21.2 % over its closing price on Friday — and more than double the price before Novo went public with its initial offer.

It's down about 14 % to $ 2.45 on Thursday at the time of publishing, a far cry from the company's stock price of over $ 14 per share in 2012.

Mylan (MYL) will pay $ 205 per share in cash and stock for the Ireland - based drugmaker, representing a 24.2 % premium over its closing price Tuesday.

Strike Energy's share price has been on a white knuckle ride over the last few weeks as investors desperately try to work out if it is going to be the next large cap gas producer in Australia, or fail whilst daring to create a new technical frontier in the search for coal seam gas riches.

Cowen lowered its rating for the photo messenger's shares to underperform from market perform, predicting a 30 percent decline in stock price over the next year.

Microsoft Corp., which is in Redmond, Washington, is paying $ 196 for each share of LinkedIn Corp., a 50 per cent premium over the stock's closing price of $ 131.08 on Friday.

In preparation for testimony before the House of Commons finance committee in Ottawa on March 10, I pulled together some thoughts on three aspects of the impact of the oil - price crash on oil sands projects and policies, and I thought I'd share them with you here over this and the next couple of postIn preparation for testimony before the House of Commons finance committee in Ottawa on March 10, I pulled together some thoughts on three aspects of the impact of the oil - price crash on oil sands projects and policies, and I thought I'd share them with you here over this and the next couple of postin Ottawa on March 10, I pulled together some thoughts on three aspects of the impact of the oil - price crash on oil sands projects and policies, and I thought I'd share them with you here over this and the next couple of posts.

After a healthy run earlier this year, shares of Salesforce took a hit in June, falling 8 percent before finding a floor of support at the stock's 50 - day moving average, a technical indicator that smooths out a stock's random price fluctuations over a given time.

Louisiana - Pacific said it will pay C$ 3.76 per share for all of the remaining common shares in the Canadian lumber company, resulting in an approximate 30 per cent premium over the company's closing price of C$ 2.89 on Sept. 3.

Cost - cutting by health insurers and concerns over drug pricing have made CVS's pharma - benefits unit seem like a liability to some investors; and in the head - to - head fight, Walgreens has grabbed some market share.

«I think there's a lot of focus upon the top line in the bank and over near - term we have been fairly flat on the top line, but if you look back over the last nine months, actually the top line is up about 5 percent,» Halford said about the share price move.

Over Agon's tenure, L'Oréal's revenue ($ 28.6 billion in 2016) and share price have steadily grown, thanks to global expansion, savvy acquisitions, and an aggressive focus on digital.

The cash and shares deal could also provide a potential exit route for Walmart, as Asda, which it bought in 1999 for 6.7 billion pounds, has been struggling to grow over the last five years as discounters Aldi and Lidl attract its price - conscious customers.

In what might represent the concerns over Proton, Citi, for one, noted that the deal would improve the valuation of the seller, raising its target price for DRB - Hicom's shares to 2.30 ringgit from 1.86 ringgit, keeping a Buy / High Risk call on the stock.

For that reason, Northrop shares edged up only 0.3 % in early trading Monday, suggesting that, while the deal made lots of sense over the long term, the price is pretty full and the buyer has less practice than some at integrating new businesses, especially big ones.

During his tenure as CEO, he presided over a roughly 70 % decline in the company's share price, not to mention cost overruns and delays with the respect to Bombardier's C Series program.

Apollo said it will pay $ 17.12 per share in cash for ClubCorp, a 30.7 percent premium over its closing price on Friday, but less than the 12 - month high of $ 17.50 the shares reached in February, on investor expectations that a sale process first reported by Reuters in January would be successful.

Dai - ichi Life Co., a Japanese life insurance company, has agreed to buy Birmingham, Ala. - basedProtective Life Corp. (NYSE: PL) for $ 5.7 billion, or $ 70 per share in cash (19 % premium over yesterday's closing price.

Redstone and daughter Shari have been trying to get rid of Dauman for months, arguing that he has failed to build value at the company and has presided over a huge drop in the share price (VIAB).

In addition to a $ 1 million base salary and $ 2 million performance bonus, the Waterloo, Ontario, company will give him 13 million BlackBerry restricted share units, worth $ 85 million based on the current stock price, that will vest over five years.

And a huge hit in the mall turned into an even bigger bonanza on the stock market, where Lulu's share price has sky - rocketed by 1,888 % in just over two years.

That may explain why Japan's Suntory jumped ahead of a number of European suitors, including France's Pernod Ricard, to bid for Beam last month — offering to pay Beam stockholders $ 83.50 per share, a 25 % premium over the stock's then - market price of around $ 67, in addition to assuming some $ 2.4 billion in company debt.

But interest from the underwriters was such that the same shares were offered instead at $ 18 — and doubled in price over their first two weeks of trading.

The purchase gave another boost to the company's share price, which had already gone from $ 40 to over $ 60 in 2014, with a full year total stockholder return of 64 %.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

In fact, with strong management and sustained execution, we believe it could carry a per - share price higher than $ 133 over time.

A participant who is granted an ISO does not recognize taxable income at the time the ISO is granted or upon its exercise, but the excess of the aggregate fair market value of the shares acquired on the exercise date (ISO shares) over the aggregate exercise price paid by the participant is included in the participant's income for alternative minimum tax purposes.